A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)
Clinical trial NCT07083401 · RECRUITING
Trial details
- NCT number
- NCT07083401
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-05
- Primary completion
- 2026-07-05
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.